About
Endologix LLC is a California-based medical device company founded in 1992, specializing in minimally invasive technologies for treating vascular diseases, particularly aortic disorders like abdominal aortic aneurysms (AAA). Headquartered in Irvine, the company is dedicated to improving patient outcomes through innovative therapeutic solutions and high-quality clinical evidence. Endologix develops and markets a range of endovascular devices, including the AFX endovascular AAA system, the VELA proximal endograft, and the Ovation abdominal stent graft system. These products are designed to address complex vascular anatomies and are supported by robust clinical data. The company also focuses on enhancing physician training through innovative methods, such as virtual reality, to improve procedural skills and patient care. With manufacturing facilities in California, Endologix sells its products directly in the U.S. and several other countries, as well as through distributors in various international markets. The company serves vascular surgeons, interventional radiologists, and healthcare providers, aiming to meet the needs of patients with complex vascular conditions.
Technologies
Keywords
Company Information
- Employees450
- Founded1992
- Annual Revenue$114000000
- Total Funding$415018100
Location
2 Musick, Irvine, California, United States, 92618
